Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Psychoneuroendocrinology ; 128: 105199, 2021 06.
Article in English | MEDLINE | ID: mdl-33933894

ABSTRACT

While opioid addiction has reached pandemic proportions, we still lack a good understanding of how the administration of opioids interacts with cognitive functions. Error processing - the ability to detect erroneous actions and correct one's behaviour afterwards - is one such cognitive function that might be susceptible to opioidergic influences. Errors are hypothesised to induce aversive negative arousal, while opioids have been suggested to reduce aversive arousal induced by unpleasant and stressful stimuli. Thus, this study investigated whether the acute administration of an opioid would affect error processing. In a double-blind between-subject study, 42 male volunteers were recruited and received either 0.2 mg buprenorphine (a partial µ-opioid receptor agonist and κ-opioid receptor antagonist) or a placebo pill before they performed a stimulus-response task provoking errors. Electroencephalograms (EEG) were recorded while participants performed the task. We observed no group differences in terms of reaction times, error rates, and affective state ratings during the task between buprenorphine and control participants. Additional measures of adaptive control, however, showed interfering effects of buprenorphine administration. On the neural level, decreased Pe (Error Positivity) amplitudes were found in buprenorphine compared to control participants following error commission. Further, frontal delta oscillations were decreased in the buprenorphine group after all responses. Our neural results jointly demonstrate a general reduction in error processing in those participants who received an opioid before task completion, thereby suggesting that opioids might have indeed the potential to dampen motivational error signals. Importantly, the effects of the opioid were evident in more elaborate error processing stages, thereby impacting on processes of conscious error appraisal and evidence accumulation.


Subject(s)
Analgesics, Opioid/pharmacology , Buprenorphine/administration & dosage , Buprenorphine/pharmacology , Motivation/drug effects , Analgesics, Opioid/administration & dosage , Analgesics, Opioid/adverse effects , Buprenorphine/adverse effects , Delta Rhythm/drug effects , Electroencephalography , Humans , Male , Narcotic Antagonists/administration & dosage , Narcotic Antagonists/pharmacology , Young Adult
2.
J Biol Chem ; 276(52): 49410-8, 2001 Dec 28.
Article in English | MEDLINE | ID: mdl-11598144

ABSTRACT

Translational regulation plays an important role in development. In terminally differentiating cells a decrease in translation rate is common, although the regulatory mechanisms are unknown. We utilized 32Dcl3 myeloblast cells to investigate translational regulation during granulocyte colony-stimulating factor (G-CSF)-induced differentiation. G-CSF causes a significant decrease in translation rate compared with interleukin-3, which is a mitogen for these cells. Although these two cytokines exhibit modest differences in their effect on translation factor phosphorylation, they exhibit dramatic differences in their effect on ribosomal abundance and ribosomal DNA transcription. However, because both cytokines stimulate cell cycling, G-CSF induces a dissociation of ribosomal biogenesis from cell cycle progression. This uncoupling of ribosomal biogenesis from cell cycle progression appears to be closely related to the transmission of a differentiation signal, because it is not observed in cells expressing a carboxyl-terminally truncated G-CSF receptor, which supports proliferation but not differentiation of these cells. Because a similar event occurs early in differentiation of murine erythroleukemic cells, this suggests that ribosomal content is a common target of differentiating agents.


Subject(s)
Cell Cycle/physiology , Cell Differentiation/physiology , Granulocyte Colony-Stimulating Factor/pharmacology , Myeloid Cells/physiology , Protein Biosynthesis/physiology , Receptors, Granulocyte Colony-Stimulating Factor/chemistry , Ribosomes/metabolism , Animals , Cell Line , Flow Cytometry , Granulocyte Colony-Stimulating Factor/chemistry , Humans , Interleukin-3/pharmacology , Myeloid Cells/cytology , Myeloid Cells/drug effects , Peptide Initiation Factors/metabolism , Phosphorylation , Protein Structure, Tertiary , RNA, Ribosomal, 18S/genetics , RNA, Ribosomal, 18S/metabolism , Receptors, Granulocyte Colony-Stimulating Factor/metabolism , Transcription, Genetic/physiology
3.
J Biol Chem ; 274(42): 30109-14, 1999 Oct 15.
Article in English | MEDLINE | ID: mdl-10514498

ABSTRACT

Rat pheochromocytoma (PC12) cells were stably transfected with either wild type or mutated human von Hippel-Lindau tumor suppressor protein (hpVHL). These proteins have opposing effects on regulating expression of the gene encoding tyrosine hydroxylase (TH), the rate-limiting enzyme in catecholamine synthesis. Whereas wild type hpVHL represses levels of TH mRNA and protein 5-fold, a truncated pVHL mutant, pVHL(1-115), induces accumulation of TH mRNA and protein 3-fold. hpVHL-induced inhibition of TH gene expression does not involve either a decrease in TH mRNA stability or repression of TH promoter activity. However, repression results from inhibition of RNA elongation at a downstream region of the TH gene. This elongation pause is accompanied by hpVHL sequestration in the nuclear extracts of elongins B and C, regulatory components of the transcription elongation heterotrimer SIII (elongin A/B/C). Hypoxia, a physiological stimulus for TH gene expression, alleviates the elongation block. A truncated pVHL mutant, pVHL(1-115), stimulates TH gene expression by increasing the efficiency of TH transcript elongation. This is the first report showing pVHL-dependent regulation of specific transcript elongation in vivo, as well as dominant negative activity of pVHL mutants in pheochromocytoma cells.


Subject(s)
Cell Hypoxia , Ligases , Proteins/physiology , RNA, Messenger/genetics , Tumor Suppressor Proteins , Tyrosine 3-Monooxygenase/genetics , Ubiquitin-Protein Ligases , Animals , Down-Regulation , Elongin , Gene Expression Regulation/genetics , Genes, Tumor Suppressor , Humans , PC12 Cells , Proteins/genetics , Proteins/metabolism , Rats , Transcription Factors/metabolism , Transfection , Von Hippel-Lindau Tumor Suppressor Protein
4.
Am J Physiol ; 274(1): C167-74, 1998 01.
Article in English | MEDLINE | ID: mdl-9458725

ABSTRACT

In the current study, we investigated links between O2-regulated H2O2 formation and the hypoxic induction of mRNA for tyrosine hydroxylase (TH), the rate-limiting enzyme in catecholamine synthesis, in O2-sensitive PC-12 cells. During exposure of PC-12 cells to 5% O2, H2O2 concentration decreased by 40% as measured with 2',7'-dichlorofluorescein (DCF). Treatment with H2O2 reduced TH mRNA during normoxia and prevented the induction of TH mRNA during hypoxia. Treatment with catalase or N-(2-mercaptopropionyl)-glycine, a reducing antioxidant agent that decreases H2O2 concentration, also induced TH mRNA. Deferoxamine (DF), an iron chelator, failed to affect H2O2 formation but induced TH mRNA in normoxia and hypoxia. CoCl2 led to a decrease in H2O2 at 20 h of treatment but induced TH mRNA during normoxia and hypoxia before it affected H2O2. In conclusion, TH gene expression correlates inversely with H2O2 formation. DF and CO2+ seem to affect TH gene expression in the mechanism downstream from the H2O2 formation rather than by interfering with the H2O2-generating activity of the O2 sensor.


Subject(s)
Antioxidants/pharmacology , Cell Hypoxia , Gene Expression Regulation, Enzymologic/physiology , Hydrogen Peroxide/pharmacology , Transcription, Genetic , Tyrosine 3-Monooxygenase/biosynthesis , Acetylcysteine/pharmacology , Actins/biosynthesis , Amitrole/pharmacology , Animals , Biosensing Techniques , Catalase/pharmacology , Deferoxamine/pharmacology , Gene Expression Regulation, Enzymologic/drug effects , Heme , Kinetics , Oxygen/analysis , PC12 Cells , RNA, Messenger/biosynthesis , Rats , Tiopronin/pharmacology , Transcription, Genetic/drug effects
5.
Kidney Int ; 51(2): 585-90, 1997 Feb.
Article in English | MEDLINE | ID: mdl-9027744

ABSTRACT

Reduced oxygen tension (hypoxia) leads to increased stability of mRNA for tyrosine hydroxylase (TH), the rate limiting enzyme in biosynthesis of catecholamine neurotransmitters. Hypoxia increases the half life of TH mRNA from 10 to 30 hours. The increased stability of TH mRNA during hypoxia results from fast enhanced binding of a cytoplasmic protein (hypoxia inducible protein, HIP) to a pyrimidine-rich sequence within the 3' untranslated region (3'UTR) of TH mRNA. This novel cis-element is referred to as hypoxia-inducible protein binding site (HIPBS) and is located between bases 1551 and 1578 of the 3' UTR of TH mRNA. We identified that the (U/C)(C/U)CCCU motif within the HIPBS represents the optimum protein-binding site. Mutations within this region that abolish protein binding prevent also regulation of TH mRNA stability during hypoxia. UV-crosslinking and SDS-PAGE analysis of the HIPBS-protein complexes showed the presence of a major 50 kDa complex. The formation of the complex was augmented when protein extracts were obtained from PC12 cells exposed to 5% O2. Importantly, formation of the 50 kDa complex was also increased when protein extracts were obtained from carotid bodies or superior cervical ganglia from rats exposed to 10% hypoxia for twenty-four hours.


Subject(s)
Cell Hypoxia/genetics , Oxygen/metabolism , Tyrosine 3-Monooxygenase/genetics , Animals , Base Sequence , Binding Sites/genetics , Cell Hypoxia/physiology , Gene Expression Regulation, Enzymologic , Mutation , PC12 Cells , Protein Binding , RNA, Messenger/genetics , RNA, Messenger/metabolism , RNA-Binding Proteins/genetics , RNA-Binding Proteins/metabolism , Rats
SELECTION OF CITATIONS
SEARCH DETAIL
...